Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Symptom control and health-related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study. | Clin Transl Allergy | 2023 | 36825519 | PubTator, text mining | PubMed |
| Prognostication refinement in NPM1-mutated acute myeloid leukemia stratified by FLT3-ITD status with different induction doses of cytarabine. | Cancer Med | 2023 | 36808479 | PubTator, text mining | PubMed |
| Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. | Brain | 2023 | 36806388 | PubTator, text mining | PubMed |
Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methods. | Toxicol Appl Pharmacol | 2023 | 36801311 | PubTator, text mining | PubMed |
| Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. | J Natl Med Assoc | 2023 | 36801148 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators to overcome drug resistance in cancers. | Signal Transduct Target Ther | 2023 | 36797239 | PubTator, text mining | PubMed |
| Transcriptome-wide association study of circulating IgE levels identifies novel targets for asthma and allergic diseases. | Front Immunol | 2023 | 36793728 | PubTator, text mining | PubMed |
| Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. | Molecules | 2023 | 36771172 | PubTator, text mining | PubMed |
| Transporter-Mediated Drug Delivery. | Molecules | 2023 | 36770817 | PubTator, text mining | PubMed |
| Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment. | Molecules | 2023 | 36770689 | PubTator, text mining | PubMed |
| Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs. | Int J Mol Sci | 2023 | 36769250 | PubTator, text mining | PubMed |
| Kidney Drug Transporters in Pharmacotherapy. | Int J Mol Sci | 2023 | 36769175 | PubTator, text mining | PubMed |
| Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). | Cancers (Basel) | 2023 | 36765586 | PubTator, text mining | PubMed |
| Activity-based CRISPR scanning uncovers allostery in DNA methylation maintenance machinery. | Elife | 2023 | 36762644 | PubTator, text mining | PubMed |
| Revisiting the bromination of 3β-hydroxycholest-5-ene with CBr4/PPh3 and the subsequent azidolysis of the resulting bromide, disparity in stereochemical behavior. | Beilstein J Org Chem | 2023 | 36761473 | PubTator, text mining | PubMed |
| Metabolic stress-induced human beta-cell death is mediated by increased intracellular levels of adenosine. | Front Endocrinol (Lausanne) | 2023 | 36761184 | PubTator, text mining | PubMed |
| Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation. | Hypertension | 2023 | 36756872 | PubTator, text mining | PubMed |
| hENT1's role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients. | BMC Gastroenterol | 2023 | 36755224 | PubTator, text mining | PubMed |
| Molecular and structural characterization of a novel high-prevalence antigen of the Augustine blood group system. | Transfusion | 2023 | 36744388 | PubTator, text mining | PubMed |
| Purinergic signaling: Diverse effects and therapeutic potential in cancer. | Front Oncol | 2023 | 36741002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=14